Stock Track | Niagen Bioscience (NAGE) Soars 5.09% as Analyst Report Highlights Significant Undervaluation

Stock Track

Aug 13, 2025

Shares of Niagen Bioscience (NAGE) surged 5.09% during intraday trading on Tuesday, as investors reacted to a recent analyst report highlighting the stock's potential undervaluation. The report, which analyzed undervalued stocks based on cash flows, placed NAGE among the top 10 undervalued stocks in the United States.

According to the analysis, Niagen Bioscience is currently trading at $9.82, significantly below its estimated fair value of $19.02. This suggests a potential discount of 48.4%, making it an attractive option for value investors. The report's findings may have prompted increased buying interest, contributing to the stock's notable rise.

While specific company news for Niagen Bioscience was not provided, the broader market context shows investors are currently seeking opportunities in undervalued stocks amidst market fluctuations and uncertain economic conditions. As the U.S. markets navigate potential shifts in monetary policy and inflationary trends, stocks like NAGE that offer a significant discount to their estimated fair value may be garnering increased attention from bargain-hunting investors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1181651115"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1181651115\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1181651115?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-13 02:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181651115","market":"sg","top_or_hot":-1,"title":"Stock Track | Niagen Bioscience (NAGE) Soars 5.09% as Analyst Report Highlights Significant Undervaluation","media":"Stock Track","content":"<p>Shares of Niagen Bioscience (NAGE) surged 5.09% during intraday trading on Tuesday, as investors reacted to a recent analyst report highlighting the stock's potential undervaluation. The report, which analyzed undervalued stocks based on cash flows, placed NAGE among the top 10 undervalued stocks in the United States.</p>\n\n<p>According to the analysis, Niagen Bioscience is currently trading at $9.82, significantly below its estimated fair value of $19.02. This suggests a potential discount of 48.4%, making it an attractive option for value investors. The report's findings may have prompted increased buying interest, contributing to the stock's notable rise.</p>\n\n<p>While specific company news for Niagen Bioscience was not provided, the broader market context shows investors are currently seeking opportunities in undervalued stocks amidst market fluctuations and uncertain economic conditions. As the U.S. markets navigate potential shifts in monetary policy and inflationary trends, stocks like NAGE that offer a significant discount to their estimated fair value may be garnering increased attention from bargain-hunting investors.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Niagen Bioscience (NAGE) Soars 5.09% as Analyst Report Highlights Significant Undervaluation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Niagen Bioscience (NAGE) Soars 5.09% as Analyst Report Highlights Significant Undervaluation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-08-13 02:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Niagen Bioscience (NAGE) surged 5.09% during intraday trading on Tuesday, as investors reacted to a recent analyst report highlighting the stock's potential undervaluation. The report, which analyzed undervalued stocks based on cash flows, placed NAGE among the top 10 undervalued stocks in the United States.</p>\n\n<p>According to the analysis, Niagen Bioscience is currently trading at $9.82, significantly below its estimated fair value of $19.02. This suggests a potential discount of 48.4%, making it an attractive option for value investors. The report's findings may have prompted increased buying interest, contributing to the stock's notable rise.</p>\n\n<p>While specific company news for Niagen Bioscience was not provided, the broader market context shows investors are currently seeking opportunities in undervalued stocks amidst market fluctuations and uncertain economic conditions. As the U.S. markets navigate potential shifts in monetary policy and inflationary trends, stocks like NAGE that offer a significant discount to their estimated fair value may be garnering increased attention from bargain-hunting investors.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NAGE","symbol_name":"Niagen Bioscience","start_time":0,"source_url":"","article_id":"1181651115","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181651115","pubTimestamp":1755023304,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Niagen Bioscience (NAGE) surged 5.09% during intraday trading on Tuesday, as investors reacted to a recent analyst report highlighting the stock's potential undervaluation. The report,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NAGE":"Niagen Bioscience"},"translate_title":"股票追踪|Niagen Bioscience(NAGE)飙升5.09%，分析师报告强调估值严重低估","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NAGE":1},"content_text":"Shares of Niagen Bioscience (NAGE) surged 5.09% during intraday trading on Tuesday, as investors reacted to a recent analyst report highlighting the stock's potential undervaluation. The report, which analyzed undervalued stocks based on cash flows, placed NAGE among the top 10 undervalued stocks in the United States.\nAccording to the analysis, Niagen Bioscience is currently trading at $9.82, significantly below its estimated fair value of $19.02. This suggests a potential discount of 48.4%, making it an attractive option for value investors. The report's findings may have prompted increased buying interest, contributing to the stock's notable rise.\nWhile specific company news for Niagen Bioscience was not provided, the broader market context shows investors are currently seeking opportunities in undervalued stocks amidst market fluctuations and uncertain economic conditions. As the U.S. markets navigate potential shifts in monetary policy and inflationary trends, stocks like NAGE that offer a significant discount to their estimated fair value may be garnering increased attention from bargain-hunting investors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}